• Esperion Therapeutics (NASDAQ:ESPR) Rating Increased to Buy at StockNews.com

    Source: Buzz FX / 07 Nov 2024 02:32:16   America/New_York


    Esperion Therapeutics (NASDAQ:ESPR) Rating Increased to Buy at StockNews.com Written by MarketBeat November 7, 2024 Share Link copied to clipboard. Esperion Therapeutics ( NASDAQ:ESPR - Get Free Report ) was upgraded by research analysts at
    Read more...
Share on,